ArticleBioengineering (Basel, Switzerland)2023
A New Breakpoint to Classify 3D Voxels in MRI: A Space Transform Strategy with 3t2FTS-v2 and Its Application for ResNet50-Based Categorization of Brain Tumors.
Article in Bioengineering (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 3 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Three-dimensional (3D) image analyses are frequently applied to perform classification tasks. Herein, 3D-based machine learning systems are generally used/generated by examining two designs: a 3D-based deep learning model or a 3D-based task-specific framework. However, except for a new approach named 3t2FTS, a promising feature transform operating from 3D to two-dimensional (2D) space has not been efficiently investigated for classification applications in 3D magnetic resonance imaging (3D MRI). In other words, a state-of-the-art feature transform strategy is not available that achieves high accuracy and provides the adaptation of 2D-based deep learning models for 3D MRI-based classification. With this aim, this paper presents a new version of the 3t2FTS approach (3t2FTS-v2) to apply a transfer learning model for tumor categorization of 3D MRI data. For performance evaluation, the BraTS 2017/2018 dataset is handled that involves high-grade glioma (HGG) and low-grade glioma (LGG) samples in four different sequences/phases. 3t2FTS-v2 is proposed to effectively transform the features from 3D to 2D space by using two textural features: first-order statistics (FOS) and gray level run length matrix (GLRLM). In 3t2FTS-v2, normalization analyses are assessed to be different from 3t2FTS to accurately transform the space information apart from the usage of GLRLM features. The ResNet50 architecture is preferred to fulfill the HGG/LGG classification due to its remarkable performance in tumor grading. As a result, for the classification of 3D data, the proposed model achieves a 99.64% accuracy by guiding the literature about the importance of 3t2FTS-v2 that can be utilized not only for tumor grading but also for whole brain tissue-based disease classification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.